GL1X · GenesisL1 explorer

MolNFT v2 · #124537 · protein

Design and Optimization of Biaryl Ether Aryl Sulfonamides as Selective Inhibitors of NaV1.7: Discovery of Clinical Candidate PF-05089771

MolNFT v2 record #124537 on GenesisL1: PDB 5K7K, “Design and Optimization of Biaryl Ether Aryl Sulfonamides as Selective Inhibitors of NaV1.7: Discovery of Clinical…”. Protein, 477 residues. 3D structure, sequence proof, BLAST…

PDB
5K7K
Type
protein
Length
477 residues
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.